Beta
Pentobarbital
medication Under reviewPentobarbital is a short-acting barbiturate that acts primarily on the central nervous system by binding to GABA-A receptors, potentiating the inhibitory effects of GABA. This prolongs the opening of chloride channels, leading to neuronal hyperpolarization and CNS depression. It also inhibits glutamate activity, enhancing its sedative properties. At low doses, it induces sedation and sleep; at higher doses, it provides anticonvulsant effects and can induce coma.
Research summary
Scientific evidence on pentobarbital in healthy human subjects is extremely limited, as it is not used as a supplement but as a prescription barbiturate for medical sedation, seizure control, and pre-anesthesia. No controlled studies were identified involving healthy humans for supplemental benefits, with research confined to clinical or pathological contexts. Consensus views it as a controlled substance with high risk of dependence and overdose, not suitable for healthy use.
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Research
No studies found yet. Request research to discover relevant studies.
Community updates
No updates yet for this supplement.
Be the first to share your experience!